Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

被引：4
|
作者：
Kim, Young-Hak [1 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 380卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：989 / 990
页数：2
相关论文
共 50 条
  • [1] Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Yokoi, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Kim, Y. -C.
    Karapetis, C. S.
    Hiret, S.
    Ostoros, G.
    Kubota, K.
    Gray, J. E.
    Paz-Ares, L.
    de Castro Carpeno, J.
    Wadsworth, C.
    Melillo, G.
    Jiang, H.
    Huang, Y.
    Dennis, P. A.
    Ozguroglu, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1919 - 1929
  • [2] Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer REPLY
    Antonia, Scott J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10): : 990 - 990
  • [3] Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
    Tomasini, Pascale
    Greillier, Laurent
    Boyer, Arnaud
    Jeanson, Arnaud
    Barlesi, Fabrice
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S1032 - S1036
  • [4] Durvalumab in Stage III Non-Small-Cell Lung Cancer
    Copur, Mehmet S.
    Gauchan, Dron
    Ramaekers, Ryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09): : 868 - 868
  • [5] Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer
    Jung, Hyun Ae
    Noh, Jae Myoung
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Pyo, Hongryull
    Ahn, Yong Chan
    Park, Keunchil
    [J]. LUNG CANCER, 2020, 146 : 23 - 29
  • [6] Durvalumab Induces Sustained Survival Benefit After Concurrent Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
    Pujol, Jean-Louis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1271 - +
  • [7] Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC)
    Socinski, Mark A.
    Ozguroglu, Mustafa
    Villegas, Augusto
    Daniel, Davey
    Vicente, David
    Murakami, Shuji
    Hui, Rina
    Gray, Jhanelle E.
    Park, Keunchil
    Vincent, Mark
    Mann, Helen
    Newton, Michael
    Dennis, Phillip A.
    Antonia, Scott J.
    [J]. CLINICAL LUNG CANCER, 2021, 22 (06) : 549 - 561
  • [8] Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer
    Edwards, Donna M.
    Sankar, Kamya
    Alseri, Aaren
    Jiang, Ralph
    Schipper, Matthew
    Miller, Sean
    Dess, Kathryn
    Strohbehn, Garth W.
    Moghanaki, Drew
    Ramnath, Nithya
    Green, Michael D.
    Bryant, Alex K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (04): : 963 - 970
  • [9] Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Mooradian, Meghan J.
    Cai, Ling
    Wang, Alice
    Qiao, Yao
    Chander, Pratibha
    Whitaker, Ryan M.
    [J]. JAMA NETWORK OPEN, 2024, 7 (04) : e247542
  • [10] Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer
    Friedel, G
    Hruska, D
    Budach, W
    Wolf, M
    Kyriss, T
    Hürtgen, M
    Eulenbruch, HP
    Dierkesmann, R
    Toomes, H
    [J]. LUNG CANCER, 2000, 30 (03) : 175 - 185
12345